Sanofi
COMPOSITIONS COMPRISING ANTI-CD38 ANTIBODIES AND LENALIDOMIDE
Last updated:
Abstract:
Disclosed herein are compositions and kits which comprise anti-CD38 antibodies and lenalidomide compounds. Also disclosed are methods for treating cancers, such as multiple myeloma, in subjects with the compositions and kits.
Status:
Application
Type:
Utility
Filling date:
5 Jun 2019
Issue date:
13 Feb 2020